Safety Study of a Selective Cytopheretic Device (SCD) in Patients With Acute Renal Failure

NACompletedINTERVENTIONAL
Enrollment

35

Participants

Timeline

Start Date

February 28, 2010

Primary Completion Date

May 31, 2011

Study Completion Date

May 31, 2011

Conditions
Acute Renal Failure
Interventions
DEVICE

Selective cytopheretic device (SCD)

The selective cytopheretic device (SCD) is comprised of tubing, connectors and a hemofilter cartridge. The device is connected in series to a commercially available Continuous Renal Replacement Therapy (CRRT) device. Blood from the CRRT circuit is diverted after the CRRT hemofilter through to the extra capillary space (ECS) of the SCD. Blood circulates through this space and is returned to the patient via the venous return line of the CRRT circuit. Regional citrate anticoagulation is used for the entire CRRT and SCD blood circuits.

Trial Locations (7)

20037

George Washington University, Washington D.C.

35294

University of Alabama Birmingham, Birmingham

37404

Memorial Hospital, Chattanooga

55905

Mayo Clinic, Rochester

77030

University of Texas, Houston

80230

Denver Nephrology, Denver

92103

University of California San Diego, San Diego

All Listed Sponsors
collaborator

Baim Institute for Clinical Research

OTHER

collaborator

Medtox

INDUSTRY

lead

SeaStar Medical

INDUSTRY